World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 34

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Checklist of Responsibilities for the Scientific Editor of This Article

Publishing Process of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3877)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

293

WORD

HTML

2000

Figures (1-1)

Tables (1-1)

223

Sum=2688

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

152

Download

247

Sum=399

Publishing Process of This Article

Item

Count

Browse

224

Download

566

Sum=790

Sep 14, 2022 (publication date) through Sep 26, 2023

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Sposito C, Citterio D, Virdis M, Battiston C, Droz Dit Busset M, Flores M, Mazzaferro V. Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma. World J Gastroenterol 2022; 28(34): 4929-4942 [PMID: 36160651 DOI: 10.3748/wjg.v28.i34.4929]
URL:	https://www.wjgnet.com/1007-9327/full/v28/i34/4929.htm

Number	Citing Articles
1	Yu-Xue Gao, Qi-Qi Ning, Peng-Xiang Yang, Yuan-Yue Guan, Peng-Xiang Liu, Meng-Lu Liu, Lu-Xin Qiao, Xiang-Hua Guo, Tong-Wang Yang, De-Xi Chen. Recent advances in recurrent hepatocellular carcinoma therapy. World Journal of Hepatology 2023; 15(4): 460-476 doi: 10.4254/wjh.v15.i4.460 Abstract(137) \| Core Tip(127) \| Full Article(HTML)(702) \| Full Article with Cover (PDF)-2294K(95) \| Full Article (Word)-592K(14) \| Audio-15705K(1) \| Peer-Review Report-234K(9) \| Answering Reviewers-112K(9) \| Full Article (PDF)-1017K(40) \| Times Cited (0) \| Total Visits (1460) \| Open
2	Xin Jin, Xiaoting Ma, Dong Zhao, Lin Yang, Nan Ma. Immune microenvironment and therapeutic progress of recurrent hepatocellular carcinoma after liver transplantation. Translational Oncology 2023; 28: 101603 doi: 10.1016/j.tranon.2022.101603
3	2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III Recommendations. Journal of Clinical and Experimental Hepatology 2023; doi: 10.1016/j.jceh.2023.08.005